/
Other
Interaction
59
Pipeline Programs↗
44
Active Trials↗
171
Companies Involved↗
Interaction is a moderately active landscape with 59 programs across 171 companies. The most active players are Daewon Pharmaceutical Co., Ltd., Cascade Pharmaceuticals, Inc, Jiangsu Simcere Pharmaceutical Co., Ltd.. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical15
Phase 137
Phase 25
Approved
No programs
Analysis
Trial Status
1,102
clinical trials
Completed977 · 89%
Unknown status43 · 4%
Not yet recruiting27 · 2%
Terminated24 · 2%
Withdrawn14 · 1%
Recruiting12 · 1%
Other5 · 0%
Clinical Trials
Trial Activity
1102 trials
A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants
Recruiting·IInstitut de Recherches Internationales Servier (I.R.I.S.)·Phase 1·NCT07235774·28 enrolled
Interaction of Volatile Anesthetics With Magnesium
Recruiting·—·Phase 4·NCT05261516·96 enrolled
Opioid Drug Interaction Study
Recruiting·—·Phase 1/2·NCT06757140·25 enrolled
Page 1 of 74
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)